- Report
- October 2024
- 196 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
Fenoverine is a drug used to treat gastrointestinal disorders, such as irritable bowel syndrome (IBS) and functional dyspepsia. It is a muscarinic receptor antagonist, meaning it blocks the action of the neurotransmitter acetylcholine, which is involved in the regulation of gastrointestinal motility. Fenoverine is available in both oral and rectal formulations, and is generally well tolerated with few side effects.
The market for fenoverine is growing, as it is increasingly being used to treat a variety of gastrointestinal disorders. It is becoming increasingly popular due to its efficacy and safety profile, as well as its availability in both oral and rectal formulations. Additionally, its low cost and ease of use make it an attractive option for many patients.
Some companies in the fenoverine market include Novartis, Merck, Pfizer, and Sanofi. Show Less Read more